These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 16475708
1. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells. Tenta R, Sourla A, Lembessis P, Koutsilieris M. Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708 [Abstract] [Full Text] [Related]
2. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells. Tenta R, Sourla A, Lembessis P, Luu-The V, Koutsilieris M. Horm Metab Res; 2005 Oct; 37(10):593-601. PubMed ID: 16278781 [Abstract] [Full Text] [Related]
3. Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells. Tenta R, Tiblalexi D, Sotiriou E, Lembessis P, Manoussakis M, Koutsilieris M. Prostate; 2004 May 01; 59(2):120-31. PubMed ID: 15042612 [Abstract] [Full Text] [Related]
4. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells. McCauley LK, Koh AJ, Beecher CA, Cui Y, Decker JD, Franceschi RT. J Bone Miner Res; 1995 Aug 01; 10(8):1243-55. PubMed ID: 8585429 [Abstract] [Full Text] [Related]
9. Regulation of parathyroid hormone/parathyroid hormone-related protein receptor expression by osteoblast-deposited extracellular matrix in a human osteoblast-like cell line. Hausmann S, Law FM, Bonjour JP, Feyen J, Rizzoli R. J Cell Physiol; 1995 Oct 01; 165(1):164-71. PubMed ID: 7559797 [Abstract] [Full Text] [Related]
10. Characterisation of ligand binding to the parathyroid hormone/parathyroid hormone-related peptide receptor in MCF7 breast cancer cells and SaOS-2 osteosarcoma cells. Alokail MS, Peddie MJ. Cell Biochem Funct; 2007 Oct 01; 25(2):139-47. PubMed ID: 16170852 [Abstract] [Full Text] [Related]
13. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Guise TA, Chirgwin JM. Clin Orthop Relat Res; 2003 Oct 01; (415 Suppl):S32-8. PubMed ID: 14600590 [Abstract] [Full Text] [Related]
16. Effects of transforming growth factor-beta1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells. Sellers RS, LeRoy BE, Blomme EA, Tannehill-Gregg S, Corn S, Rosol TJ. Prostate; 2004 Mar 01; 58(4):366-73. PubMed ID: 14968437 [Abstract] [Full Text] [Related]
18. Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model. Halapas A, Lembessis P, Mourouzis I, Pantos C, Cokkinos DV, Sourla A, Koutsilieris M. Exp Physiol; 2008 Feb 01; 93(2):237-46. PubMed ID: 17911357 [Abstract] [Full Text] [Related]
19. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line. Li X, Drucker DJ. Cancer Res; 1993 Jul 01; 53(13):2980-6. PubMed ID: 8319205 [Abstract] [Full Text] [Related]
20. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts. Benayahu D, Fried A, Shamay A, Cunningham N, Blumberg S, Wientroub S. J Cell Biochem; 1994 Sep 01; 56(1):62-73. PubMed ID: 7528753 [Abstract] [Full Text] [Related] Page: [Next] [New Search]